Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism.

M R M Mainenti, P S Vigário, P F S Teixeira, M D L Maia, F P Oliveira, M Vaisman
Author Information
  1. M R M Mainenti: Endocrine Clinic, University Hospital Clementino Fraga Filho, Rio de Janeiro, Brazil. miriam.mainenti@hotmail.com

Abstract

Although muscle metabolism and exercise capacity seem to be affected in patients with subclinical hypothyroidism, there is little evidence indicating improvement of the exercise tolerance due to levothyroxine (L-T(4)) replacement. The aim of the present study was to verify possible cardiopulmonary changes during exercise in patients with subclinical hypothyroidism on L-T(4) replacement with a normal serum TSH for six months. Twenty-three patients with subclinical hypothyroidism were randomized into treated (no.=11) and untreated (no.=12) patients. A cardiopulmonary test was performed with a treadmill, using the modified Balke protocol. Heart rate, oxygen uptake, minute ventilation and other cardiopulmonary parameters were assessed at the 5th minute of exercise. FT4 levels increased while TSH normalized after hormone replacement. Oxygen uptake decreased significantly after hormone replacement (24.1+/-6.3 vs 17.1+/-4.2 ml x kg x min(-1); p=0.03).Minute ventilation also showed an enhanced performance in treated patients (28.0+/-8.1 vs 23.5+/-5.6 l x min(-1); p=0.03), as did the heart rate (128+/-17 vs 121+/-17 bpm; p=0.03). There were no changes in the untreated group. The results demonstrate that submaximal cardiopulmonary exercise performance improved after six months of TSH normalization and this improvement can help enhance the ability to carry out daily life activities in patients with subclinical hypothyroidism.

References

  1. Circulation. 2007 Oct 9;116(15):1725-35 [PMID: 17923583]
  2. Horm Metab Res. 2005 Sep;37(9):538-44 [PMID: 16175490]
  3. Genome Res. 2002 Feb;12(2):281-91 [PMID: 11827947]
  4. Arch Gerontol Geriatr. 2007 Jan-Feb;44(1):13-9 [PMID: 16621071]
  5. J Clin Endocrinol Metab. 2001 Mar;86(3):1110-5 [PMID: 11238494]
  6. Thyroid. 1996 Oct;6(5):397-402 [PMID: 8936662]
  7. Recent Prog Horm Res. 2004;59:31-50 [PMID: 14749496]
  8. J Clin Endocrinol Metab. 2007 May;92(5):1715-23 [PMID: 17299073]
  9. Int J Cardiol. 2005 Aug 3;103(1):1-6 [PMID: 16061115]
  10. Endocr Rev. 2005 Aug;26(5):704-28 [PMID: 15632316]
  11. Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1067-73 [PMID: 15657093]
  12. Ann Intern Med. 2002 Dec 3;137(11):904-14 [PMID: 12458990]
  13. J Clin Endocrinol Metab. 2002 Sep;87(9):4350-5 [PMID: 12213897]
  14. Arq Bras Endocrinol Metabol. 2007 Dec;51(9):1485-92 [PMID: 18209891]
  15. Thyroid. 2000 Aug;10(8):665-79 [PMID: 11014311]
  16. Endocr J. 2005 Feb;52(1):95-101 [PMID: 15758564]
  17. Horm Metab Res. 2008 Jan;40(1):50-5 [PMID: 18085502]
  18. J Clin Endocrinol Metab. 2005 Jul;90(7):4057-62 [PMID: 15855263]
  19. Med Sci Monit. 2004 May;10(5):CR229-32 [PMID: 15114275]
  20. J Clin Endocrinol Metab. 2004 May;89(5):2099-106 [PMID: 15126526]
  21. Circ J. 2006 Oct;70(10):1332-6 [PMID: 16998269]
  22. Horm Metab Res. 2005 Sep;37(9):563-5 [PMID: 16175495]
  23. JAMA. 2004 Jan 14;291(2):228-38 [PMID: 14722150]
  24. Am J Cardiol. 2003 Jun 1;91(11):1327-30 [PMID: 12767425]
  25. Thyroid. 2002 Jun;12(6):473-81 [PMID: 12165109]
  26. J Clin Endocrinol Metab. 1997 Oct;82(10):3315-8 [PMID: 9329360]
  27. J Clin Endocrinol Metab. 1999 Jun;84(6):2064-7 [PMID: 10372711]
  28. Sports Med. 2000 Jun;29(6):373-86 [PMID: 10870864]
  29. Am J Med. 2006 Jul;119(7):541-51 [PMID: 16828622]

MeSH Term

Adult
Athletic Performance
Exercise
Exercise Test
Exercise Tolerance
Female
Heart Rate
Hormone Replacement Therapy
Humans
Hypothyroidism
Middle Aged
Oxygen Consumption
Pulmonary Ventilation
Thyroxine

Chemicals

Thyroxine

Word Cloud

Created with Highcharts 10.0.0exercisepatientssubclinicalhypothyroidismreplacementcardiopulmonaryTSHvsxp=003performanceimprovementlevothyroxineL-T4changessixmonthstreatednountreatedrateuptakeminuteventilationhormonemin-1AlthoughmusclemetabolismcapacityseemaffectedlittleevidenceindicatingtolerancedueaimpresentstudyverifypossiblenormalserumTwenty-threerandomized=11=12testperformedtreadmillusingmodifiedBalkeprotocolHeartoxygenparametersassessed5thFT4levelsincreasednormalizedOxygendecreasedsignificantly241+/-63171+/-42mlkgMinutealsoshowedenhanced280+/-81235+/-56lheart128+/-17121+/-17bpmgroupresultsdemonstratesubmaximalimprovednormalizationcanhelpenhanceabilitycarrydailylifeactivitiesEffect

Similar Articles

Cited By